ANAB
ANAPTYSBIO, INC
NASDAQ · Healthcare · Biotechnology · US
$49.24
+5.64%Forward multiples
Based on analyst estimates
- P/E forward
- 5.47x
- P/E 2026E
- 9.70x
- P/E 2027E
- 7.29x
- P/E 2028E
- 6.92x
- P/S forward
- 9.83x
Trailing multiples
Trailing twelve months
- P/E TTM
- 7.29x
- PEG TTM
- 0.22x
- Price / book
- 139.07x
- Price / sales
- 6.20x
- Price / cash flow
- 81.41x
Enterprise value
- Enterprise value
- $1.6B
- EV / sales
- 6.64x
- EV / EBITDA
- 17.16x
- EV / EBIT
- 11.78x
- Market cap
- $1.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026